Olema Pharmaceuticals, Inc. (OLMA) Tops Q2 EPS by 24c

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q2 EPS of ($0.49), $0.24 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c